Santhera Pharmaceuticals to share latest on rollout of AGAMREE and future strategic priorities
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need, announced that at its Capital Markets Day (CMD) in …